Reducing cardiovascular risk (CVR) is the main focus of diabetes mellitus (DM)
management nowadays. Complex pathogenic mechanisms that are the subject of this …

Introduction Novel atherogenic lipid indices, including non-high-density lipoprotein
cholesterol (non-HDL-C) which is calculated by subtracting the HDL-C value from the total …

Remnant cholesterol (RC) is a highly atherogenic lipid. Previous studies have shown that
RC was closely associated with many metabolism-related diseases. However, the …

Low-density-lipoprotein cholesterol (LDL-c) guides lipid-lowering therapy, although other
lipid parameters could better reflect cardiovascular disease (CVD) risk. Discordance …

Background Dyslipidemias are associated with atherosclerosis and cardiovascular
diseases. Recently, non-high-density lipoprotein cholesterol (non-HDL-c) has emerged as a …

Background Non-high-density lipoprotein-cholesterol (non-HDL-C) has been identified as a
potential biomarker for metabolic syndrome (MetS). However, its predictive capability for …

Background Specific biomarkers for metabolic syndrome (MetS) may improve diagnostic
specificity for clinical information. One of the main pathophysiological mechanisms of MetS …

This study aimed to investigate the association between seaweed consumption and the
odds of developing metabolic syndrome in middle-aged and elderly Koreans. The study …

Background Non-high-density lipoprotein cholesterol (non-HDL-C) is considered as a
valuable predictor for dyslipidemia and subclinical atherosclerosis which can be an …

Аннотация Цель исследования—оценить средние уровни холестерина липопротеинов
невысокой плотности (ХСнеЛПВП) и распространенность гиперхолестеринемии …